PLUS THERAPEUTICS, INC. (PSTV) › Capital ExpendituresPLUS THERAPEUTICS, INC. (PSTV) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $221.0K2010: $610.0K2011: $560.0K2012: $1.20M2013: $519.0K2014: $764.0K2015: $611.0K2016: $67.0K2017: $295.0K2018: $133.0K2019: $67.0K2023: $160.0K2024: $146.0K2025: $67.0K$67.0K2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$67.0K-54.1%2024$146.0K-8.8%2023$160.0K—2019$67.0K-49.6%2018$133.0K-54.9%2017$295.0K+340.3%2016$67.0K-89.0%2015$611.0K-20.0%2014$764.0K+47.2%2013$519.0K-56.9%2012$1.20M+115.0%2011$560.0K-8.2%2010$610.0K+176.0%2009$221.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share